Fig. 1 · Structure
Documents & Downloads
CCTA-1523
ABCG2 Inhibitor
CCTA-1523 is a potent and selective reversible inhibitor of the ATP-binding cassette transporter G2 (ABCG2). This compound demonstrates notable cytotoxic effects, contributing to its anticancer activity. CCTA-1523 is suitable for research applications focused on cancer biology and drug resistance mechanisms associated with ABCG2.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 1616271-41-0 |
| Applications | ABCG2 Inhibitor |
| Formula | C16H15Cl2NO3 |
| Molecular Weight | 340.20 |
| SMILES | O=C(C(Cl)Cl)NC1=CC(C2=CC=C(C(OC)=C2)OC)=CC=C1 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.